nvp-1805
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 8, 2019 (NCT03802526)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05354713 | Phase 1 | May 4, 2022 | NVP Healthcare |
| NCT04905342 | Phase 1 | Aug 7, 2021 | H Plus Yangji Hospital, Navipharm Corporation |
| NCT04780386 | Phase 1 | Aug 29, 2020 | H Plus Yangji Hospital, Navipharm Corporation |
| NCT03802526 | Phase 1 | Mar 8, 2019 | Gachon University, Navipharm Corporation |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Navipharm Corporation | For profit | 3 | 3 | 1 | 2019 |
| H Plus Yangji Hospital | Academic/Hospital | 2 | 0 | 1 | 2020 |
| Gachon University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| NVP Healthcare | For profit | 1 | 1 | 1 | 2022 |
4 organizations
Page 1 / 1